Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1016/j.bjane.2014.11.004
Brazilian Journal of Anesthesiology
Scientific Article

Use of tranexamic acid in primary total knee replacement: effects on perioperative blood loss

Uso do ácido tranexâmico em artroplastia total primária de joelho: repercussões na perda sanguínea perioperatória

Daniel Volquind; Remi Antônio Zardo; Bruno Costamilan Winkler; Bruno Bertagnolli Londero; Natália Zanelatto; Gisele Perondi Leichtweis

Downloads: 0
Views: 897

Abstract

ABSTRACT BACKGROUND AND OBJECTIVES: The use of tranexamic acid in primary total knee replacement surgeries has been the subject of constant study. The strategies to reduce bleeding are aimed at reducing the need for blood transfusion due to the risks involved. In this study we evaluated the use of tranexamic acid in reducing bleeding, need for blood transfusion, and prevalence of postoperative deep vein thrombosis in primary total knee replacement. METHOD: 62 patients undergoing primary total knee replacement were enrolled in the study, from June 2012 to May 2013, and randomized to receive a single dose of 2.5 g of intravenous tranexamic acid (Group TA) or saline (Group GP), 5 min before opening the pneumatic tourniquet, respectively. Hemoglobin, hematocrit, and blood loss were recorded 24 h after surgery. Deep vein thrombosis was investigated during patient's hospitalization and 15 and 30 days after surgery in review visits. RESULTS: There was no demographic difference between groups. Group TA had 13.89% decreased hematocrit (p = 0.925) compared to placebo. Group TA had a decrease of 12.28% (p = 0.898) in hemoglobin compared to Group GP. Group TA had a mean decrease of 187.35 mL in blood loss (25.32%) compared to group GP (p = 0.027). The number of blood transfusions was higher in Group GP (p = 0.078). Thromboembolic events were not seen in this study. CONCLUSION: Tranexamic acid reduced postoperative bleeding without promoting thromboembolic events.

Keywords

Anesthesia, Tranexamic acid, Knee prosthesis, Bleeding, Blood transfusion

Resumo

RESUMO JUSTIFICATIVA E OBJETIVOS: O uso do ácido tranexâmico, em cirurgias de artroplastia total primária de joelho, tem sido objeto de constante estudo. As estratégias para redução de sangramento visam à redução da necessidade de transfusão de sangue devido aos riscos que apresentam. Neste estudo, propomos a avaliação do uso do ácido tranexâmico na redução do sangramento, na necessidade de transfusão de sangue e na prevalência de trombose venosa profunda (TVP) pós-operatória em artroplastia total primária de joelho. MÉTODO: Foram estudados 62 pacientes submetidos à artroplastia primária total de joelho, de junho de 2012 a maio de 2013, randomizados para receber ácido tranexâmico 2,5 g endovenoso (grupo AT), em dose única, ou soro fisiológico (grupo GP), cinco minutos antes da abertura do torniquete pneumático, respectivamente. Foram feitas dosagens de hemoglobina e hematócrito e medida a perda sanguínea 24 horas após a cirurgia. A TVP foi pesquisada durante a internação do paciente, 15 e 30 dias após a cirurgia nas consultas de revisão. RESULTADOS: Não houve diferenças demográficas entre os grupos estudados. O grupo GT apresentou queda do hematócrito 13,89% (p = 0,925) comparado com o grupo placebo. O grupo GT apresentou diminuição de 12,28% (p = 0,898) da hemoglobina comparado com o grupo GP. O grupo GT apresentou uma diminuição média de 187,35 ml nas perdas sanguíneas (25,32%) quando comparado com o grupo GP (p = 0,027). O número de transfusões sanguíneas foi maior no grupo GP (p = 0,078). Eventos tromboembólicos não foram evidenciados neste estudo. CONCLUSÕES: O ácido tranexâmico diminuiu o sangramento pós-operatório sem promover eventos tromboembólicos.

Palavras-chave

Anestesia, Ácido tranexâmico, Prótese do joelho, Sangramento, Transfusão de sangue

References

Michel JWP, Schlüter-Brust KU, Eysel P. The epidemiology, eti- ology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010;107:152-62.

Carlson JL, Duff A, Berlin JA. Perioperative blood trans- fusion and postoperative mortality. JAMA. 1998;279:199-205.

Baron DM, Hochrieser H, Posch M. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth. 2014;113:416-23.

Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. The Knee. 2003;10:375-7.

Kotzé A, Carter LA, Scally AJ. Effect of patient blood manage- ment programme on preoperative anaemia, transfusion rate, and outcome after primary hip and knee arthroplasty a quality improvement cycle. Br J Anaesth. 2012;108:943-52.

Snyder GL, Grinberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth. 2010;105:106-15.

Wheatley T, Veitch PS. Effect of blood transfusion on postop- erative immunocompetence. Br J Anaesth. 1997;78:489-92.

Garneti N, Field J. Bone bleeding during total hip arthro- plasty after administration of tranexamic acid. J Arth. 2004;19:488-92.

Jansen J, Andreica S, Claeys M. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth. 1999;83:596-601.

MacGillivray RG, Tarabichi SB. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty - a prospective, ran- domized double blind study. J Arth. 2011;26:24-8.

McConnel JS, Shewale S, Munro NA. Reducing blood loss in primary knee arthroplasty a prospective randomized con- trolled trial of tranexamic acid and fibrin spray. The Knee. 2012;19:295-8.

Orpen NM, Little C, Walker G. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty a prospective randomised controlled trial of 29 patients. The Knee. 2006;13:106-10.

Benoni G, Lethagen S, Fredin H. The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res. 1997;85:195-206.

Tarwala R, Dorr LD, Gilbert PK. Tourniquet use during cementation only during total knee arthroplasty a randomized trial. Clin Orthop Relat Res. 2014;472:169-74.

Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA a prospec- tive randomized controlled trial. Clin Orthop Relat Res. 2011;469:2874-80.

Maniar RN, Kumar G, Singhi T. Most effective regimen of tranexamic acid in knee arthroplasty a prospective random- ized controlled study in 240 patients. Clin Orthop Relat Res. 2012;470:2605-12.

Gandhi R, Evans HMK, Mahomed SR. Tranexamic acid and reduction of blood loss in total knee and hip arthroplasty a meta-analysis. BMC Res Notes. 2013;6:184.

Zufferey PJ, Miquet M, Quenet S. Tranexamic acid in hip fracture surgery a randomized controlled trial. Br J Anaesth. 2010;104:23-30.

Camarasa MA, Ollé G, Serra- Prat M. Efficacy of aminocaproic, tranexamic acid in the control of bleeding dur- ing total knee replacement a randomized clinical trial. Br J Anaesth. 2006;96:576-82.

Kagoma YK, Crowther MA, Douketis J. Use of antifibri- nolytic therapy to reduce transfusion in patients undergoing orthopedic surgery a systematic review of randomized trials. Thromb Res. 2009;123:687-96.

Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356:2301-11.

Ballantyne A, Walmstey P, Brenkel I. Reduction of blood transfusion rates in unilateral total knee arthroplasty by the introduction of a simple blood transfusion protocol. The Knee. 2003;10:379-84.

Zadzilka JD, Stulberg BN. Blood conservation in total kneearthroplasty hedging your bets. Semin Arthro. 2011;22:150-2.

Poeran J, Rasul R, Suzuki S. Tranexamic acid useand postoperative outcomes in patients undergoing totalhip or knee arthroplasty in United States retrospectiveanalysis of effectiveness and safety. BMJ. 2014;349:g4829.

5dcd76330e88254f25bf58f1 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections